[1]
Goldman JD,Julian K, Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical transplantation. 2019 Sep
[PubMed PMID: 30793386]
[2]
Duane S,Vellinga A,Murphy AW,Cormican M,Smyth A,Healy P,Moore M,Little P,Devane D, COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults. Trials. 2019 Feb 7
[PubMed PMID: 30732617]
[3]
Behzadi P,Behzadi E,Yazdanbod H,Aghapour R,Akbari Cheshmeh M,Salehian Omran D, A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica. 2010 Apr;
[PubMed PMID: 21977133]
Level 3 (low-level) evidence
[4]
Byron JK, Urinary Tract Infection. The Veterinary clinics of North America. Small animal practice. 2019 Mar
[PubMed PMID: 30591189]
Level 3 (low-level) evidence
[5]
Karamali M,Shafabakhsh R,Ghanbari Z,Eftekhar T,Asemi Z, Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression. Journal of cellular physiology. 2019 Jan 4;
[PubMed PMID: 30609029]
[6]
Rank EL,Lodise T,Avery L,Bankert E,Dobson E,Dumyati G,Hassett S,Keller M,Pearsall M,Lubowski T,Carreno JJ, Antimicrobial Susceptibility Trends Observed in Urinary Pathogens Obtained From New York State. Open forum infectious diseases. 2018 Nov;
[PubMed PMID: 30539040]
[7]
Talan DA,Takhar SS,Krishnadasan A,Abrahamian FM,Mower WR,Moran GJ,EMERGEncy ID Net Study Group., Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1). Emerging infectious diseases. 2016 Sep
[PubMed PMID: 27532362]
[8]
Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Nov:57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6
[PubMed PMID: 23926176]
[9]
Kranz J,Schmidt S,Lebert C,Schneidewind L,Mandraka F,Kunze M,Helbig S,Vahlensieck W,Naber K,Schmiemann G,Wagenlehner FM, The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urologia internationalis. 2018;
[PubMed PMID: 29539622]
[10]
Suárez Fernández ML,Ridao Cano N,Álvarez Santamarta L,Gago Fraile M,Blake O,Díaz Corte C, A Current Review of the Etiology, Clinical Features, and Diagnosis of Urinary Tract Infection in Renal Transplant Patients. Diagnostics (Basel, Switzerland). 2021 Aug 12
[PubMed PMID: 34441390]
[12]
Krieger JN,Ross SO,Simonsen JM, Urinary tract infections in healthy university men. The Journal of urology. 1993 May
[PubMed PMID: 8483206]
[13]
Tyagi P, Moon CH, Janicki J, Kaufman J, Chancellor M, Yoshimura N, Chermansky C. Recent advances in imaging and understanding interstitial cystitis. F1000Research. 2018:7():. pii: F1000 Faculty Rev-1771. doi: 10.12688/f1000research.16096.1. Epub 2018 Nov 9
[PubMed PMID: 30473772]
Level 3 (low-level) evidence
[14]
Pinto H,Simões M,Borges A, Prevalence and Impact of Biofilms on Bloodstream and Urinary Tract Infections: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland). 2021 Jul 8
[PubMed PMID: 34356749]
Level 1 (high-level) evidence
[15]
Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. The New England journal of medicine. 2013 Nov 14:369(20):1883-91. doi: 10.1056/NEJMoa1302186. Epub
[PubMed PMID: 24224622]
[16]
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002 May 22-29:287(20):2701-10
[PubMed PMID: 12020306]
[17]
Juthani-Mehta M, Quagliarello V, Perrelli E, Towle V, Van Ness PH, Tinetti M. Clinical features to identify urinary tract infection in nursing home residents: a cohort study. Journal of the American Geriatrics Society. 2009 Jun:57(6):963-70. doi: 10.1111/j.1532-5415.2009.02227.x. Epub
[PubMed PMID: 19490243]
[18]
Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, Hickling D, Kapoor A, Kenton KS, Kaufman MR, Rondanina MA, Stapleton A, Stothers L, Chai TC. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. The Journal of urology. 2019 Aug:202(2):282-289. doi: 10.1097/JU.0000000000000296. Epub 2019 Jul 8
[PubMed PMID: 31042112]
[19]
Nace DA,Drinka PJ,Crnich CJ, Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. Journal of the American Medical Directors Association. 2014 Feb
[PubMed PMID: 24461240]
[20]
Sundvall PD, Ulleryd P, Gunnarsson RK. Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC family practice. 2011 May 19:12():36. doi: 10.1186/1471-2296-12-36. Epub 2011 May 19
[PubMed PMID: 21592413]
Level 2 (mid-level) evidence
[21]
Pouwels KB,Hopkins S,Llewelyn MJ,Walker AS,McNulty CA,Robotham JV, Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ (Clinical research ed.). 2019 Feb 27
[PubMed PMID: 30814052]
[22]
Kulchavenya EV,Neymark AI,Borisenko DV,Kapsargin FP, [Acute uncomplicated cysititis: do we follow the guidelines?] Urologiia (Moscow, Russia : 1999). 2018 Dec
[PubMed PMID: 30742380]
[23]
Phamnguyen TJ,Murphy G,Hashem F, Single centre observational study on antibiotic prescribing adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infection. Infection, disease & health. 2019 May
[PubMed PMID: 30598405]
Level 2 (mid-level) evidence
[24]
Bono MJ, Leslie SW, Reygaert WC, Doerr C. Uncomplicated Urinary Tract Infections (Nursing). StatPearls. 2024 Jan:():
[PubMed PMID: 33760460]
[26]
Swamy S, Kupelian AS, Khasriya R, Dharmasena D, Toteva H, Dehpour T, Collins L, Rohn JL, Malone-Lee J. Cross-over data supporting long-term antibiotic treatment in patients with painful lower urinary tract symptoms, pyuria and negative urinalysis. International urogynecology journal. 2019 Mar:30(3):409-414. doi: 10.1007/s00192-018-3846-5. Epub 2018 Dec 18
[PubMed PMID: 30564872]
[27]
May M,Schostak M,Lebentrau S, Guidelines for patients with acute uncomplicated cystitis may not be a paper tiger: a call for its implementation in clinical routine. International urogynecology journal. 2019 Feb;
[PubMed PMID: 30564871]
[28]
Bellazreg F, Abid M, Lasfar NB, Hattab Z, Hachfi W, Letaief A. Diagnostic value of dipstick test in adult symptomatic urinary tract infections: results of a cross-sectional Tunisian study. The Pan African medical journal. 2019:33():131. doi: 10.11604/pamj.2019.33.131.17190. Epub 2019 Jun 21
[PubMed PMID: 31558930]
Level 2 (mid-level) evidence
[29]
Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004 Apr 15:38(8):1150-8
[PubMed PMID: 15095222]
[30]
Lee RA, Centor RM, Humphrey LL, Jokela JA, Andrews R, Qaseem A, Scientific Medical Policy Committee of the American College of Physicians, Akl EA, Bledsoe TA, Forciea MA, Haeme R, Kansagara DL, Marcucci M, Miller MC, Obley AJ. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians. Annals of internal medicine. 2021 Jun:174(6):822-827. doi: 10.7326/M20-7355. Epub 2021 Apr 6
[PubMed PMID: 33819054]
[31]
McKinnell JA,Stollenwerk NS,Jung CW,Miller LG, Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clinic proceedings. 2011 Jun
[PubMed PMID: 21576512]
[32]
Huttner A,Verhaegh EM,Harbarth S,Muller AE,Theuretzbacher U,Mouton JW, Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. The Journal of antimicrobial chemotherapy. 2015 Sep
[PubMed PMID: 26066581]
Level 1 (high-level) evidence
[33]
Sheele JM,Libertin CR,Fink I,Jensen T,Dasalla N,Lyon TD, Alkaline Urine in the Emergency Department Predicts Nitrofurantoin Resistance. The Journal of emergency medicine. 2022 Jan 6;
[PubMed PMID: 35000812]
[34]
Iravani A,Klimberg I,Briefer C,Munera C,Kowalsky SF,Echols RM, A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. The Journal of antimicrobial chemotherapy. 1999 Mar
[PubMed PMID: 10225575]
[35]
Kavatha D,Giamarellou H,Alexiou Z,Vlachogiannis N,Pentea S,Gozadinos T,Poulakou G,Hatzipapas A,Koratzanis G, Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrobial agents and chemotherapy. 2003 Mar;
[PubMed PMID: 12604518]
[36]
Warren JW,Abrutyn E,Hebel JR,Johnson JR,Schaeffer AJ,Stamm WE, Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1999 Oct;
[PubMed PMID: 10589881]
[37]
Nicolle LE, Harding GK, Thomson M, Kennedy J, Urias B, Ronald AR. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. The Journal of infectious diseases. 1988 Jun:157(6):1239-42
[PubMed PMID: 3259613]
[38]
Stein GE, Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clinical therapeutics. 1999 Nov
[PubMed PMID: 10890258]
[40]
Schulz GS,Schütz F,Spielmann FVJ,Uglione da Ros L,de Almeida JS,Lopes Ramos JG, iSingle Dose Antibiotic Therapy for Urinary Infections during Pregnancy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2022 Jan 7;
[PubMed PMID: 34995367]
Level 1 (high-level) evidence
[41]
Hatlen TJ, Flor R, Nguyen MH, Lee GH, Miller LG. Oral fosfomycin use for pyelonephritis and complicated urinary tract infections: a 1 year review of outcomes and prescribing habits in a large municipal healthcare system. The Journal of antimicrobial chemotherapy. 2020 Jul 1:75(7):1993-1997. doi: 10.1093/jac/dkaa126. Epub
[PubMed PMID: 32303061]
[42]
Wald-Dickler N, Lee TC, Tangpraphaphorn S, Butler-Wu SM, Wang N, Degener T, Kan C, Phillips MC, Cho E, Canamar C, Holtom P, Spellberg B. Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study. Open forum infectious diseases. 2022 Jan:9(1):ofab620. doi: 10.1093/ofid/ofab620. Epub 2021 Dec 23
[PubMed PMID: 35036466]
Level 2 (mid-level) evidence
[43]
Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. International journal of antimicrobial agents. 2003 Oct:22 Suppl 2():73-8
[PubMed PMID: 14527775]
[44]
Nicolle LE,Madsen KS,Debeeck GO,Blochlinger E,Borrild N,Bru JP,Mckinnon C,O'Doherty B,Spiegel W,Van Balen FA,Menday P, Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scandinavian journal of infectious diseases. 2002;
[PubMed PMID: 12195873]
[45]
Nace DA,Perera SK,Hanlon JT,Saracco S,Anderson G,Schweon SJ,Klein-Fedyshin M,Wessel CB,Mulligan M,Drinka PJ,Crnich CJ, The Improving Outcomes of UTI Management in Long-Term Care Project (IOU) Consensus Guidelines for the Diagnosis of Uncomplicated Cystitis in Nursing Home Residents. Journal of the American Medical Directors Association. 2018 Sep;
[PubMed PMID: 30037743]
Level 3 (low-level) evidence
[46]
Cox L, He C, Bevins J, Clemens JQ, Stoffel JT, Cameron AP. Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2017 Sep:11(9):E350-E354. doi: 10.5489/cuaj.4434. Epub
[PubMed PMID: 29382457]
[48]
Ziadeh T,Chebel R,Labaki C,Saliba G,Helou EE, Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review. Urologia. 2022 May;
[PubMed PMID: 34612750]
Level 1 (high-level) evidence
[49]
Lo TS,Hammer KD,Zegarra M,Cho WC, Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert review of anti-infective therapy. 2014 May;
[PubMed PMID: 24689705]
[50]
Kevorkian CG,Merritt JL,Ilstrup DM, Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder. Mayo Clinic proceedings. 1984 Aug;
[PubMed PMID: 6379319]
[51]
Kranjčec B,Papeš D,Altarac S, D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World journal of urology. 2014 Feb;
[PubMed PMID: 23633128]
Level 1 (high-level) evidence
[52]
Kyriakides R,Jones P,Somani BK, Role of D-Mannose in the Prevention of Recurrent Urinary Tract Infections: Evidence from a Systematic Review of the Literature. European urology focus. 2021 Sep;
[PubMed PMID: 32972899]
Level 1 (high-level) evidence
[53]
Lenger SM,Bradley MS,Thomas DA,Bertolet MH,Lowder JL,Sutcliffe S, D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American journal of obstetrics and gynecology. 2020 Aug;
[PubMed PMID: 32497610]
Level 1 (high-level) evidence
[54]
De Nunzio C,Bartoletti R,Tubaro A,Simonato A,Ficarra V, Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives. Antibiotics (Basel, Switzerland). 2021 Apr 1;
[PubMed PMID: 33915821]
Level 3 (low-level) evidence
[55]
Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine. 2007 Jan:86(1):47-53. doi: 10.1097/MD.0b013e3180307c3a. Epub
[PubMed PMID: 17220755]
Level 3 (low-level) evidence
[56]
Thomas AA,Lane BR,Thomas AZ,Remer EM,Campbell SC,Shoskes DA, Emphysematous cystitis: a review of 135 cases. BJU international. 2007 Jul
[PubMed PMID: 17506870]
Level 3 (low-level) evidence
[57]
Perry C,Hossain M,Powell M,Raychaudhuri A,Scangarella-Oman N,Tiffany C,Xu S,Dumont E,Janmohamed S, Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants. Infectious diseases and therapy. 2022 Dec
[PubMed PMID: 36271314]
Level 1 (high-level) evidence
[58]
Fishman C,Caverly Rae JM,Posobiec LM,Laffan SB,Lerman SA,Pearson N,Janmohamed S,Dumont E,Nunn-Floyd D,Stanislaus DJ, Novel Bacterial Topoisomerase Inhibitor Gepotidacin Demonstrates Absence of Fluoroquinolone-Like Arthropathy in Juvenile Rats. Antimicrobial agents and chemotherapy. 2022 Nov 15
[PubMed PMID: 36255258]
[59]
Tiffany C,Dumont EF,Hossain M,Srinivasan M,Swift B, Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects. Clinical and translational science. 2022 Sep
[PubMed PMID: 35769034]
[60]
Biedenbach DJ,Bouchillon SK,Hackel M,Miller LA,Scangarella-Oman NE,Jakielaszek C,Sahm DF, In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens. Antimicrobial agents and chemotherapy. 2016 Jan 4;
[PubMed PMID: 26729499]
[61]
Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. The Journal of urology. 1997 Jun:157(6):2049-52
[PubMed PMID: 9146577]
Level 1 (high-level) evidence
[62]
Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. The Journal of urology. 2003 Sep:170(3):867-9
[PubMed PMID: 12913718]
Level 1 (high-level) evidence
[63]
Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. The Journal of urology. 2007 Apr:177(4):1349-53; quiz 1591
[PubMed PMID: 17382730]
Level 1 (high-level) evidence
[64]
Eldridge GR, Hughey H, Rosenberger L, Martin SM, Shapiro AM, D'Antonio E, Krejci KG, Shore N, Peterson J, Lukes AS, Starks CM. Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study. Human vaccines & immunotherapeutics. 2021 May 4:17(5):1262-1270. doi: 10.1080/21645515.2020.1834807. Epub 2020 Dec 16
[PubMed PMID: 33325785]
[65]
Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (New York, N.Y.). 1997 Apr 25:276(5312):607-11
[PubMed PMID: 9110982]
[66]
Forsyth VS,Himpsl SD,Smith SN,Sarkissian CA,Mike LA,Stocki JA,Sintsova A,Alteri CJ,Mobley HLT, Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection. mBio. 2020 Apr 28
[PubMed PMID: 32345645]
[67]
Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. The Journal of urology. 2013 Dec:190(6):1981-9. doi: 10.1016/j.juro.2013.04.142. Epub 2013 Jul 15
[PubMed PMID: 23867306]
Level 1 (high-level) evidence
[68]
Wang Q,Sun M,Ma C,Lv H,Lu P,Wang Q,Liu G,Hu Z,Gao Y, Emphysematous pyelonephritis and cystitis in a patient with uremia and anuria: A case report and literature review. Medicine. 2018 Nov
[PubMed PMID: 30407278]
Level 3 (low-level) evidence